May, 2009Cal. Supreme Court Paves Way for Class Action Suits Against Big Tobacco

California consumers can file class-action lawsuits against big tobacco, despite limits state voters placed on the type of litigation in 2004, the state’s Supreme Court has ruled.

Continue →

Infant Apnea Monitors Recalled, May Fail to Sound Alarm

Nearly 5,000 infant apnea monitors made by Respironics Inc. are being recalled because the devices may fail to sound an alarm during periods of stopped breathing or low heart rate, the Food and Drug Administration said. The SmartMonitor 2 Infant Apnea Monitor, models 4002 and 4003 with the serial numbers 3000033364 through 3000038740, are included in the FDA Class I recall. The products were made and distributed between Jan. 16, 2008 and November 13, 2008. The SmartMonitor devices are used …

Continue →

Northfield Labs to Shut Down After FDA Rejects Proposed Blood Substitute

Northfield Laboratories, the Illinois-based maker of a human red blood cell substitute, plans to close its doors after the Food and Drug Administration refused to approve the product. Performing the necessary additional clinical research and development of PolyHeme before re-submitting the product to the FDA would be too expensive, Northfield said. Also, there is too much uncertainty about whether the agency would approve the drug even then, the company said. Northfield said it is unlikely that it could raise enough …

Continue →

Some Madoff Investors and Associates May Have Known of Fraud, Prosecutors Say

Authorities working to unravel the $65 billion Ponzi scheme run by former investment advisor Bernard Madoff now say a few high-profile clients and friends may have known of the fraud and assisted in the scheme.

Continue →

FDA Broadens Approval for Antipsychotic Drug Risperdal to Treat Bipolar Disorder

An injectible form of Risperdal Consta, a drug previously approved to treat schizophrenia and bipolar mania, may now be used for patients with bipolar I disorder, the Food and Drug Administration said. The FDA broadened its approvals for the drug made by Janssen Pharmaceuticals, a division of Johnson & Johnson. The pill form of Risperdal Consta was already approved as a standalone schizophrenia treatment and for use in conjunction with lithium or valproate. It also is used to treat autism. …

Continue →

LexisNexis® Legal News Podcast for May 18, 2009

A number of recent state Supreme Court rulings involving insurance, and, the Wisconsin high court denies the city of Milwaukee’s petition for review of a defense ruling in a lead case. Hear these and other stories from LexisNexis® Mealey’s™ Insurance, Insurance Bad Faith, Lead Litigation and Class Actions Reports. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.

Continue →

Antiepileptic Drugs

Audience: Neuropsychiatric healthcare professionals, other healthcare professionals, patients
[UPDATE 05/05/2009] FDA notified healthcare professionals that it approved updated labeling for antiepileptic drugs used to treat epilepsy, psychiatric…


Continue →

Costco Workers Allege Mistreatment; Class Action Suit Filed in California

A class-action lawsuit has been filed in a San Diego County court accusing retail giant Costco Wholesale Corp. of mistreating employees by forcing them to remain at work every night past the time they are getting paid.

Continue →

Baxter: Latest Heparin Deaths, Injuries Not Our Fault

Drug maker Baxter International Inc. says its blood-thinning drug heparin is not responsible for the recent deaths of two patients and severe injury to a third at a Delaware hospital. Earlier this week, officials at Beebe Medical Center in Lewes notified Baxter and the Food and Drug Administration that patients had died or been severely injured after being given heparin. The drug is commonly given in hospitals across the United States to prevent blood clots from forming during open-heart surgery …

Continue →

Parents Who Favor ‘Alternative Medicine’ Ordered to Get Chemo for Cancer-Ridden Teen; Did Judge Deliver a Blow for Families’ Rights?

The parents of a 13-year-old Minnesota boy with a deadly form of cancer who wanted to use “alternative medicine” to treat their son have been ordered by a judge to seek chemotherapy and other traditional medical care for the teen.

Continue →

Recent Related Features

All Stories